Two Sigma Investments, LP Cure Vac N.V. Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Cure Vac N.V. stock. As of the latest transaction made, Two Sigma Investments, LP holds 73,770 shares of CVAC stock, worth $405,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,770
Previous 114,685
35.68%
Holding current value
$405,735
Previous $391,000
47.83%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CVAC
# of Institutions
95Shares Held
10.7MCall Options Held
75.1KPut Options Held
86.7K-
Black Rock Inc. New York, NY2.25MShares$12.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.82MShares$9.99 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.63 Million10.6% of portfolio
-
Ubs Group Ag843KShares$4.64 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0308KShares$1.69 Million0.08% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1.03B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...